LMR Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-371,562
Closed -$10.9M 1808
2025
Q4
$10.9M Hold
371,562
0.02% 355
2025
Q3
$9.38M Buy
+371,562
New +$9.06M 0.04% 346
2024
Q1
Sell
-291,777
Closed -$8.35M 1288
2023
Q4
$8.35M Hold
291,777
0.1% 218
2023
Q3
$10.8M Hold
291,777
0.12% 179
2023
Q2
$11.4M Buy
291,777
+41,608
+17% +$1.63M 0.13% 177
2023
Q1
$9.13M Buy
250,169
+227,566
+1,007% +$7.18M 0.14% 177
2022
Q4
$694K Buy
+22,603
New +$702K 0.01% 796

Other funds holding RTO

LMR Partners's RTO Position: Q1 2026 in Review

LMR Partners sold out of Rentokil (RTO) in Q1 2026, closing a stake of 371,562 shares — an estimated $10.9M sold.

LMR Partners first reported a position in RTO in Q4 2022 and held it in 7 quarters. The position peaked at $11.4M in Q2 2023. 284 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • LMR Partners reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 371,562 Rentokil shares in Q1 2026, an estimated $10.9M.
  • LMR Partners first reported a position in Rentokil in Q4 2022 and held it in 7 quarters.
  • LMR Partners's Rentokil position peaked at $11.4M in Q2 2023.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.